Oakland County observatory owner seeking future-focused successor
Current owner Jim Kinsler says the observatory in Lake Angelus is completely intact. It just needs some new people to come in and move it into the future.
Anyone who steps inside will feel like they're traveling back in time.
"The scientists knew it was important for everything to be here," Kinsler said.
The first tower was built in 1930, and two more towers followed soon after.
"This thing was growing by leaps and bounds. And the original three gentlemen, it just got beyond their capability to run it very quickly," Kinsler said.
That's why it was deeded to the University of Michigan.
"One of the really significant things they did here, they took this first motion pictures of solar flares," Kinsler said.
Scientists also created a device for the U.S. Navy to help them fight against German U-boats during World War II.
"They needed a very accurate bomb site to hit those, so they developed the mark 2223 bomb site here, and it had a big effect on the outcome of the war," Kinsler said.
Eventually the university ended operations.
Kinsler credits Ed Henry, the technical director for Detroit TV , for stepping in to save it.
"He contributed, over the years, $40,000 of his own money that he earned. He's the modern hero and I'm just a guy who came along in 1991 and picked it up and carried it forward," Kinsler said.
The observatory was home to the Discovery Program — a mentoring program for young people from underserved communities in the Pontiac area.
"I would love to hear from people that were here during the Discovery Program," Kinsler said.
Kinsler says big things are happening now and groups of people are coming in to help modernize the facility.
"I mean, we've got a to-do list of around 25 projects," he said. "Everything from just cleaning up, you know, just getting everything in better shape."
Kinsler says this observatory was the foundation for modern day astronomical research.
"You got to have a good foundation, or what you build on top is worthless," he said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
3 days ago
- CNBC
Pandemic darlings Moderna, BioNTech are now on two different paths
The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies are on different paths. Both Moderna and BioNTech helped pioneer mRNA, or messenger RNA, technology. Moderna staked its entire identity around mRNA, while BioNTech saw it as one piece of a broader portfolio focused on immunology and oncology. The pandemic gave both companies a chance to prove mRNA's promise of using the body's own immune system to protect against viruses or treat diseases. Covid vaccines have generated roughly $45 billion in sales for each company, earning them each about $20 billion since their rollout in late 2020. But despite parallel booms after the pandemic, the vaccine makers have since taken their businesses in different directions — and Wall Street has noticed. The two companies have spent their Covid vaccine windfall differently: Moderna doubled down on its mRNA pipeline, while BioNTech used the money to do deals and diversify, including into one of the hottest emerging areas of cancer drugs. Today, Moderna has about $8.4 billion in cash; the German-based BioNTech has €15.9 billion (or $18.2 billion). The divergence of the two companies is even more stark in their stock performance. Over the past year, Moderna shares have slid about 72%; BioNTech shares have gained nearly 29%. "Just their name was made based off the pandemic and the vaccines that they very quickly brought to people around the world to help get us through that period of time," said Evercore ISI analyst Cory Kasimov. "But the approach they're taking now and the outlook for these two companies is distinctly different at this point." Investors will get a fresh look at both companies' performance as they post quarterly results in the coming days. Moderna is set to report Friday morning, followed by BioNTech on Monday morning. Moderna used its Covid cash to build out its mRNA portfolio, particularly vaccines. It invested in shots for flu, RSV and lesser-known viruses like cytomegalovirus and norovirus. "From our perspective, the pandemic really showed that the science of what we're doing worked, and the natural sort of response to that was to continue down that path and do more," said Moderna President Stephen Hoge. Funding such a large pipeline wasn't cheap. The company has started slashing expenses as sales of its Covid vaccine slide and its RSV vaccine struggles to find a foothold. But the clock is running, said Leerink analyst Mani Foroohar. "We're moving into a time where being a vaccine company is going to be more expensive, tedious and onerous," Foroohar said, citing changes at the Food and Drug Administration under the leadership of Health and Human Services Secretary Robert F. Kennedy Jr., who has expressed skepticism about vaccines. Foroohar in 2022 pointed out what he saw as a Shakespearean tragic flaw in Moderna's business model. That shortcoming, in his view, is that Moderna scaled its pipeline assuming mRNA technology would be the tool for all problems instead of a solution for some problems. Hoge said Moderna's "really good at making mRNA medicines" and decided to focus on doing that. "The reality is that we think over the last 10 years, that focus has actually made us successful, and in the pandemic, it certainly had a big impact and obviously was something that sets us up for the more diverse pipeline we have right now," Hoge said. "So we recognize that we may be going through some cycles, but we're pretty confident in the long-term trajectory we're on, and we're looking forward over the years ahead to showing with all these additional medicines what we're really capable of." Meanwhile, BioNTech decided to use the proceeds from its Covid vaccine to diversify. Out of the limelight as partner Pfizer took the lead on selling the companies' shot, BioNTech expanded into promising new cancer technologies. Most importantly, it acquired a bispecific antibody targeting the proteins PD-L1 and VEG-F. That technology promises to build on – and possibly best – the success that Merck has found with Keytruda, a cancer drug with nearly $30 billion in sales last year alone. That thesis still needs to be proven in large, global clinical trials, but BioNTech is already seeing that deal pay off. Bristol Myers Squibb in June announced it would pay up to $11 billion to partner with BioNTech to codevelop the experimental drug, which BioNTech acquired for a fraction of that. BioNTech in 2023 initially paid Biotheus $55 million up front to license the drug outside China before acquiring the company outright earlier this year for up to $1 billion. "[BioNTech] found an asset, they developed it, and then they got a pharma partner, it's like a dream," said BMO analyst Evan David Seigerman. "So they're really strategic in that, and I think they're adding a lot of diversification, which makes the story a lot less risky if you're just focused on mRNA, vaccines and Covid, and that's super risky, in my view." At the same time, hopes are high that BioNTech's bispecific antibody drug will work, meaning any disappointment ahead could hurt the stock. Investors are watching forthcoming Phase 3 trial results from Summit Therapeutics, which is testing a similar drug for lung cancer. Those data could help — or hurt — BioNTech's stock while it awaits data from its own studies, which could take until 2028. For Moderna, investors want to see if sales of its Covid and RSV vaccines can rebound. The company is also seeking FDA approval for an mRNA flu shot. But at this point, the most intense focus is on Moderna's Phase 3 trial for a personalized cancer treatment for melanoma, said RBC Capital Markets analyst Luca Issi. Moderna may be able to share the first interim data as soon as next year, Hoge said, though the company can't promise an exact date since it's an event-driven study. That means enough people in the trial need to relapse before Moderna can analyze whether its treatment kept cancer from returning longer. If the treatment succeeds, it could launch in 2027 or 2028, Hoge said. That leaves Moderna largely dependent on its vaccines until then. An ongoing patent dispute over Moderna's Covid-19 shot could also eat into the company's cash, analysts say, adding they expect the legal proceedings to play out next year. Time will tell whether the divergent strategies win over Wall Street long term.
USA Today
3 days ago
- USA Today
Military now won't cut off satellite data used by hurricane forecasters, climate scientists
Microwave data from a trio of defense department satellites will continue flowing to NOAA to help inform sea ice research and hurricane forecasts. A plan that would have stopped the flow of essential forecast data from a trio of aging military satellites during the middle of hurricane season has been nixed after widespread pushback. Statements from the U.S. Navy and the National Oceanic and Atmospheric Administration confirmed on July 29 that data flow from microwave sounders on the trio of Department of Defense Satellites would continue until sometime next year as originally planned, backtracking from earlier announcements in May and June. The sounders track rain and winds over the oceans and ice, said Walter Meier, a senior research scientist at the National Snow and Ice Data Center at the University of Colorado. Federal agencies and the military use the non-classified data for an array of computer modeling, but the information is considered vital for providing regular details about the polar regions, scientists told USA TODAY. Additionally, numerous scientists have pointed out the importance of the microwave satellite data for logging information about moisture inside hurricanes, although NOAA emphasized the agency has a "robust suite" of other hurricane forecasting tools. For monitoring sea ice, the microwave instruments provide "complete coverage of the polar regions every day and can 'see' at night,' Meier said. They are not affected by what gets reflected or refracted in the atmosphere and have operated continuously since 1987. 'That's almost 38 years-worth of sea ice data being used to track conditions in the Arctic,' he said. Scientists have similar continuity for Antarctica. Losing the microwave data would make it difficult to keep the long-term records intact. Aging satellites will continue providing data, for now The three satellites have been flying since at least 2009, Meier said. Typically planned to last three to five years, these missions have 'kind of been living on borrowed time.' So it wasn't a surprise when the military sent out notifications earlier this year that it would stop processing and distributing the data in September 2026. Just a few weeks later, for reasons that were never fully explained, the military announced it would stop providing the data on June 30, 2025, more than a year earlier than expected. That kicked off frantic discussions among Meier and hurricane forecasters about how to replace that data. In response to a huge backlash, the military extended its deadline to July 30, 2025. But on July 29, one day before the data transmissions were scheduled to stop, the Navy stated that after "feedback from government partners, officials found a way to meet modernization goals while keeping the data flowing until the sensor fails or the program formally ends in September 2026." The decision was initially reported by Michael Lowry, a meteorologist and hurricane specialist in Miami. NOAA stated there would be "no interruption" to the Defense Meteorological Satellite Program data and the agency would continue to have access to the data for the duration of the program's life span. Why satellite moisture data is important for hurricane forecasts When a hurricane is far out at sea, the microwave sensors are one of the only ways to diagnose a storm's internal structure, said Andy Hazelton, an associate scientist at the University of Miami. A current NOAA satellite with a microwave instrument has different frequencies, and does not provide the same information, the scientists said, and polar orbiters aren't as effective because they sample less frequently. Hazelton said things change fast inside tropical cyclones and forecasters need as much data as possible. Losing the microwave data would degrade hurricane forecasts, said John Cortinas, a former deputy assistant administrator for science with NOAA's Oceanic and Atmospheric Research. 'Typically, fewer observations mean less accuracy.' Losing half the microwave data available to forecasters decreases the ability to identify the most dangerous storms, the ones that intensify quickly and catch forecasters and the public off guard, said Jeff Masters, a former Hurricane Hunter research scientist and co-founder of Weather Underground. Rapid intensification: Some hurricanes suddenly explode in intensity Masters was among those who found it troubling that the loss of data could occur at a time when the frequency 'of this most dangerous type of hurricane is increasing,' There were nine such storms in the Atlantic last year, tying the record for the most in 45 years. Even the original one-month extension would have been too little time to arrange for, and fine-tune, other instruments to match the previous data for scientific continuity, Cortinas said. 'Fingers crossed' The satellite instruments, called Special Sensor Microwave Imager Sounders, are fairly low resolution and don't do a whole lot for security and warfighting support, so they aren't a priority for an agency with a mission of national security and defense, Meier said. But he wishes there had been "more recognition of the value of the products to U.S. civilians." Because the satellites are considered "very old," they're not as secure as they should be or as secure as a new system, Meier said. It's also likely the military didn't feel like it was worth it to upgrade the satellites, he said. For now, he's keeping his "fingers crossed" that the data will continue to flow and give them an extended period to find a way to replace the microwave data and ensure continuity for long-term sea ice records at the ends of the Earth. One possibility, he previously told USA TODAY, includes an agreement to use data from another government, such as the Japanese Space Agency. Dinah Voyles Pulver covers climate change, hurricanes, violent weather and other news for USA TODAY. Reach her at dpulver@ or @dinahvp on Bluesky or X or dinahvp.77 on Signal.
UPI
3 days ago
- UPI
Defense Department opts to not end satellite data for storm forecasts
An infrared satellite image of the Atlantic Ocean shows Hurricane Dorian on Sept. 6, 2019, as a Category 2 hurricane. U.S. Navy photo via Naval Research Laboratory July 30 (UPI) -- The U.S. Defense Department won't end the dispersal of key satellite weather data on Friday as planned. One month ago, the National Oceanic and Atmospheric Administration published a notice about the change by the U.S. Navy, effective July 1. Then NOAA said the change would be delayed by one month until Thursday. In an update posted Wednesday, the phase-out plans were pushed back one year. "The Fleet Numerical Meteorology and Oceanography Center (FNMOC) has announced plans to continue distribution of Defense Meteorological Satellite Program (DMSP) data beyond July 31, 2025," the update said. "As a result, there will be no interruption to DMSP data delivery." With the peak hurricane season underway, forecasters with the National Weather Service, National Hurricane Center, media outlets, private meteorologists and weather watchers had expressed concern about not getting the satellite imagery. "Crisis averted," Michael Lowry, a meteorologist at the Storm Surge Unit of the National Hurricane Center, posted on Blue Sky, noting it "means our hurricane forecast tools should stay intact." A U.S. Space Force spokesperson said in a statement that the satellites and instruments are functional and that the Department of Defense will continue to use them. A U.N. Navy official told ABC News that plans were to "phase out the data as part of the Defense Department modernization effort," but pushed it back after feedback and a "way to meet modernization goals while keeping the data flowing until the sensor fails or the program formally ends in September 2026." For 40 years, the Pentagon has operated satellites for atmospheric and ocean conditions. Special Sensor Microwave Imager Sounder Sensors onboard three DMSP satellites will be turned off. The satellites gather multiple wavelengths of light, including visible, infrared and microwave, Kim Wood, an atmospheric scientist at the University of Arizona, told Scientific American. Microwaves are used to monitor hurricanes, Wood said, "because the waves are so long they get through the tops of the clouds" and help scientists to understand a storm's inner workings, especially those that occur at night. With the real-time data, hurricane experts can see where the center of a storm forms, and hence figure out the direction where it could be headed, including land. They can see when a new eyewall forms, which helps determine intensity. That was done with Hurricane Erick earlier this month in the Pacific Ocean. The Navy uses data to track conditions for its ships. "It's not an issue of funding cuts," Mark Serreze, the director of the National Snow and Ice Data Center, a federally funded research center in Colorado, told NPR. "There are cybersecurity concerns. That's what we're being told." Nevertheless, the Trump administration has been making cuts to the federal agencies with dealing with weather. The National Hurricane Center, which is overseen by NOAA, didn't expect less-accurate forecasts. "NOAA's data sources are fully capable of providing a complete suite of cutting-edge data and models that ensure the gold-standard weather forecasting the American people deserve," NOAA communications director Kim Doster told NPR. NOAA and NASA also operate satellites that are used for forecasts. The hurricane season runs from June 1 to Nov. 30 with six so far named in the Pacific and three so far in the Atlantic.
